{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T17:06:50Z","timestamp":1761239210387},"reference-count":58,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,17]]},"DOI":"10.7759\/cureus.69616","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T01:20:01Z","timestamp":1726622401000},"source":"Crossref","is-referenced-by-count":1,"title":["Adverse Events and Efficacy of Acetazolamide in Meniere\u2019s Disease in a Vertigo Outpatient Clinic: A Retrospective Study"],"prefix":"10.7759","author":[{"given":"Teru","family":"Kamogashira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinnosuke","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Funayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Ishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2023-220184","article-title":"Combination pharmacological therapy targeting multiple mechanisms of sleep apnoea: a randomised controlled cross-over trial","volume":"79","author":"Sands SA","year":"2024","unstructured":"Sands SA, Collet J, Gell LK, et al.. Combination pharmacological therapy targeting multiple mechanisms of sleep apnoea: a randomised controlled cross-over trial. Thorax. 2024, 79:259-68. 10.1136\/thorax-2023-220184","journal-title":"Thorax"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000001017","article-title":"Fampridine and acetazolamide in EA2 and related familial EA: a prospective randomized placebo-controlled trial","volume":"11","author":"Muth C","year":"2021","unstructured":"Muth C, Teufel J, Sch\u00f6ls L, et al.. Fampridine and acetazolamide in EA2 and related familial EA: a prospective randomized placebo-controlled trial. Neurol Clin Pract. 2021, 11:e438-46. 10.1212\/CPJ.0000000000001017","journal-title":"Neurol Clin Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5334\/tohm.747","article-title":"Episodic ataxias: primary and secondary etiologies, treatment, and classification approaches","volume":"13","author":"Hassan A","year":"2023","unstructured":"Hassan A. Episodic ataxias: primary and secondary etiologies, treatment, and classification approaches. Tremor Other Hyperkinet Mov (N Y). 2023, 13:9. 10.5334\/tohm.747","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36654-8","article-title":"Optimized testing strategy for the diagnosis of GAA-FGF14 ataxia\/spinocerebellar ataxia 27B","volume":"13","author":"Bonnet C","year":"2023","unstructured":"Bonnet C, Pellerin D, Roth V, et al.. Optimized testing strategy for the diagnosis of GAA-FGF14 ataxia\/spinocerebellar ataxia 27B. Sci Rep. 2023, 13:9737. 10.1038\/s41598-023-36654-8","journal-title":"Sci Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad239","article-title":"Spinocerebellar ataxia 27B: episodic symptoms and acetazolamide response in 34 patients","volume":"5","author":"Ashton C","year":"2023","unstructured":"Ashton C, Indelicato E, Pellerin D, et al.. Spinocerebellar ataxia 27B: episodic symptoms and acetazolamide response in 34 patients. Brain Commun. 2023, 5:fcad239. 10.1093\/braincomms\/fcad239","journal-title":"Brain Commun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2005.00891.x","article-title":"Hypothesis: could Meniere's disease be a channelopathy?","volume":"35","author":"Gates P","year":"2005","unstructured":"Gates P. Hypothesis: could Meniere's disease be a channelopathy?. Intern Med J. 2005, 35:488-9. 10.1111\/j.1445-5994.2005.00891.x","journal-title":"Intern Med J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/0194599816630733","article-title":"A systematic review of diuretics in the medical management of M\u00e9ni\u00e8re's disease","volume":"154","author":"Crowson MG","year":"2016","unstructured":"Crowson MG, Patki A, Tucci DL. A systematic review of diuretics in the medical management of M\u00e9ni\u00e8re's disease. Otolaryngol Head Neck Surg. 2016, 154:824-34. 10.1177\/0194599816630733","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A4462","article-title":"Endolymphatic hydrops reversal following acetazolamide therapy: demonstration with delayed intravenous contrast-enhanced 3D-FLAIR MRI","volume":"37","author":"Sepahdari AR","year":"2016","unstructured":"Sepahdari AR, Vorasubin N, Ishiyama G, Ishiyama A. Endolymphatic hydrops reversal following acetazolamide therapy: demonstration with delayed intravenous contrast-enhanced 3D-FLAIR MRI. AJNR Am J Neuroradiol. 2016, 37:151-4. 10.3174\/ajnr.A4462","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2021.680260","article-title":"Cochlear Meniere's: a distinct clinical entity with isolated cochlear hydrops on high-resolution MRI?","volume":"8","author":"Alonso JE","year":"2021","unstructured":"Alonso JE, Ishiyama GP, Fujiwara RJ, Pham N, Ledbetter L, Ishiyama A. Cochlear Meniere's: a distinct clinical entity with isolated cochlear hydrops on high-resolution MRI?. Front Surg. 2021, 8:680260. 10.3389\/fsurg.2021.680260","journal-title":"Front Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-017-0476-z","article-title":"Current treatment options: vestibular migraine","volume":"19","author":"Lauritsen CG","year":"2017","unstructured":"Lauritsen CG, Marmura MJ. Current treatment options: vestibular migraine. Curr Treat Options Neurol. 2017, 19:38. 10.1007\/s11940-017-0476-z","journal-title":"Curr Treat Options Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0387-7604(02)00003-7","article-title":"Long-term effectiveness and side effects of acetazolamide as an adjunct to other anticonvulsants in the treatment of refractory epilepsies","volume":"24","author":"Katayama F","year":"2002","unstructured":"Katayama F, Miura H, Takanashi S. Long-term effectiveness and side effects of acetazolamide as an adjunct to other anticonvulsants in the treatment of refractory epilepsies. Brain Dev. 2002, 24:150-4. 10.1016\/s0387-7604(02)00003-7","journal-title":"Brain Dev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.51.479","article-title":"Adverse effects of intravenous acetazolamide administration for evaluation of cerebrovascular reactivity using brain perfusion single-photon emission computed tomography in patients with major cerebral artery steno-occlusive diseases","volume":"51","author":"Saito H","year":"2011","unstructured":"Saito H, Ogasawara K, Suzuki T, et al.. Adverse effects of intravenous acetazolamide administration for evaluation of cerebrovascular reactivity using brain perfusion single-photon emission computed tomography in patients with major cerebral artery steno-occlusive diseases. Neurol Med Chir (Tokyo). 2011, 51:479-83. 10.2176\/nmc.51.479","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3233\/VES-150549","article-title":"Diagnostic criteria for Meni\u00e8re's disease","volume":"25","author":"Lopez-Escamez JA","year":"2015","unstructured":"Lopez-Escamez JA, Carey J, Chung WH, et al.. Diagnostic criteria for Meni\u00e8re's disease. J Vestib Res. 2015, 25:1-7. 10.3233\/VES-150549","journal-title":"J Vestib Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1990.01870040046011","article-title":"The development of the Dizziness Handicap Inventory","volume":"116","author":"Jacobson GP","year":"1990","unstructured":"Jacobson GP, Newman CW. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1990, 116:424-7. 10.1001\/archotol.1990.01870040046011","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1965.01720310065008","article-title":"A self-rating depression scale","volume":"12","author":"Zung WW","year":"1965","unstructured":"Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965, 12:63-70. 10.1001\/archpsyc.1965.01720310065008","journal-title":"Arch Gen Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report","volume":"17","author":"Yesavage JA","year":"1982","unstructured":"Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982, 17:37-49. 10.1016\/0022-3956(82)90033-4","journal-title":"J Psychiatr Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1300\/J018v05n01_09","article-title":"9\/Geriatric Depression Scale (GDS) recent evidence and development of a shorter version","volume":"5","author":"Sheikh JI","year":"1986","unstructured":"Sheikh JI, Yesavage JA. 9\/Geriatric Depression Scale (GDS) recent evidence and development of a shorter version. Clin Gerontol. 1986, 5:165-73. 10.1300\/J018v05n01_09","journal-title":"Clin Gerontol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond AS","year":"1983","unstructured":"Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983, 67:361-70. 10.1111\/j.1600-0447.1983.tb09716.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.10.1274","article-title":"Does this patient with headache have a migraine or need neuroimaging?","volume":"296","author":"Detsky ME","year":"2006","unstructured":"Detsky ME, McDonald DR, Baerlocher MO, Tomlinson GA, McCrory DC, Booth CM. Does this patient with headache have a migraine or need neuroimaging?. JAMA. 2006, 296:1274-83. 10.1001\/jama.296.10.1274","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.56.suppl_1.s20","article-title":"Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability","volume":"56","author":"Stewart WF","year":"2001","unstructured":"Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001, 56:S20-8. 10.1212\/wnl.56.suppl_1.s20","journal-title":"Neurology"},{"key":"ref21","article-title":"A simple migraine screening instrument: validation study in Japan","volume":"42","author":"Takeshima T","year":"2015","unstructured":"Takeshima T, Sakai F, Suzuki N, et al.. A simple migraine screening instrument: validation study in Japan. Japanese J Headache. 2015, 42:134-43.","journal-title":"Japanese J Headache"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2008.02783.x","article-title":"Japanese clinical guidelines for juvenile orthostatic dysregulation version 1","volume":"51","author":"Tanaka H","year":"2009","unstructured":"Tanaka H, Fujita Y, Takenaka Y, et al.. Japanese clinical guidelines for juvenile orthostatic dysregulation version 1. Pediatr Int. 2009, 51:169-79. 10.1111\/j.1442-200X.2008.02783.x","journal-title":"Pediatr Int"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3233\/ves-2005-15405","article-title":"The minimal ice water caloric test compared with established vestibular caloric test procedures","volume":"15","author":"Schm\u00e4l F","year":"2005","unstructured":"Schm\u00e4l F, L\u00fcbben B, Weiberg K, Stoll W. The minimal ice water caloric test compared with established vestibular caloric test procedures. J Vestib Res. 2005, 15:215-24. 10.3233\/ves-2005-15405","journal-title":"J Vestib Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.131.10.857","article-title":"Extent of lesions in idiopathic sudden hearing loss with vertigo: study using click and galvanic vestibular evoked myogenic potentials","volume":"131","author":"Iwasaki S","year":"2005","unstructured":"Iwasaki S, Takai Y, Ozeki H, Ito K, Karino S, Murofushi T. Extent of lesions in idiopathic sudden hearing loss with vertigo: study using click and galvanic vestibular evoked myogenic potentials. Arch Otolaryngol Head Neck Surg. 2005, 131:857-62. 10.1001\/archotol.131.10.857","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5147-x","article-title":"Novel subtype of idiopathic bilateral vestibulopathy: bilateral absence of vestibular evoked myogenic potentials in the presence of normal caloric responses","volume":"256","author":"Fujimoto C","year":"2009","unstructured":"Fujimoto C, Murofushi T, Chihara Y, Suzuki M, Yamasoba T, Iwasaki S. Novel subtype of idiopathic bilateral vestibulopathy: bilateral absence of vestibular evoked myogenic potentials in the presence of normal caloric responses. J Neurol. 2009, 256:1488-92. 10.1007\/s00415-009-5147-x","journal-title":"J Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2014.07.028","article-title":"Involvement of vestibular organs in idiopathic sudden hearing loss with vertigo: an analysis using oVEMP and cVEMP testing","volume":"126","author":"Fujimoto C","year":"2015","unstructured":"Fujimoto C, Egami N, Kinoshita M, Sugasawa K, Yamasoba T, Iwasaki S. Involvement of vestibular organs in idiopathic sudden hearing loss with vertigo: an analysis using oVEMP and cVEMP testing. Clin Neurophysiol. 2015, 126:1033-8. 10.1016\/j.clinph.2014.07.028","journal-title":"Clin Neurophysiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.46.161","article-title":"Stevens-Johnson syndrome associated with intravenous acetazolamide administration for evaluation of cerebrovascular reactivity. Case report","volume":"46","author":"Ogasawara K","year":"2006","unstructured":"Ogasawara K, Tomitsuka N, Kobayashi M, et al.. Stevens-Johnson syndrome associated with intravenous acetazolamide administration for evaluation of cerebrovascular reactivity. Case report. Neurol Med Chir (Tokyo). 2006, 46:161-3. 10.2176\/nmc.46.161","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1977.04450080088009","article-title":"Carbonic anhydrase inhibitor side effects. Serum chemical analysis","volume":"95","author":"Epstein DL","year":"1977","unstructured":"Epstein DL, Grant WM. Carbonic anhydrase inhibitor side effects. Serum chemical analysis. Arch Ophthalmol. 1977, 95:1378-82. 10.1001\/archopht.1977.04450080088009","journal-title":"Arch Ophthalmol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5649\/jjphcs.28.1","article-title":"Pharmacokinetics and pharmacodynamics of acetazolamide in patients with intraocular pressure elevation","volume":"28","author":"Yano I","year":"2002","unstructured":"Yano I. Pharmacokinetics and pharmacodynamics of acetazolamide in patients with intraocular pressure elevation. Japanese J Pharm Heal Care Sci. 2002, 28:1-8. 10.5649\/jjphcs.28.1","journal-title":"Japanese J Pharm Heal Care Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1999.15.97","article-title":"Relationship between acetazolamide blood concentration and its side effects in glaucomatous patients","volume":"15","author":"Inatani M","year":"1999","unstructured":"Inatani M, Yano I, Tanihara H, Ogura Y, Honda Y, Inui KI. Relationship between acetazolamide blood concentration and its side effects in glaucomatous patients. J Ocul Pharmacol Ther. 1999, 15:97-105. 10.1089\/jop.1999.15.97","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000557","article-title":"Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence","volume":"7","author":"Schmickl CN","year":"2020","unstructured":"Schmickl CN, Owens RL, Orr JE, Edwards BA, Malhotra A. Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence. BMJ Open Respir Res. 2020, 7:e000557. 10.1136\/bmjresp-2020-000557","journal-title":"BMJ Open Respir Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/pl00007866","article-title":"Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial","volume":"249","author":"Vahedi K","year":"2002","unstructured":"Vahedi K, Taupin P, Djomby R, et al.. Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial. J Neurol. 2002, 249:206-11. 10.1007\/pl00007866","journal-title":"J Neurol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/01.mao.0000185057.81962.51","article-title":"Oral administration of prednisone to control refractory vertigo in M\u00e9ni\u00e8re's disease: a pilot study","volume":"26","author":"Morales-Luckie E","year":"2005","unstructured":"Morales-Luckie E, Cornejo-Suarez A, Zaragoza-Contreras MA, Gonzalez-Perez O. Oral administration of prednisone to control refractory vertigo in M\u00e9ni\u00e8re's disease: a pilot study. Otol Neurotol. 2005, 26:1022-6. 10.1097\/01.mao.0000185057.81962.51","journal-title":"Otol Neurotol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/MLG.0b013e31816927f0","article-title":"Medical management of M\u00e9ni\u00e8re's disease","volume":"118","author":"Coelho DH","year":"2008","unstructured":"Coelho DH, Lalwani AK. Medical management of M\u00e9ni\u00e8re's disease. Laryngoscope. 2008, 118:1099-108. 10.1097\/MLG.0b013e31816927f0","journal-title":"Laryngoscope"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1159\/000275597","article-title":"Treatment of M\u00e9ni\u00e8re's disease with isosorbide","volume":"44","author":"Kitahara M","year":"1982","unstructured":"Kitahara M, Takeda T, Yazawa Y, Matsubara H, Kitano H. Treatment of M\u00e9ni\u00e8re's disease with isosorbide. ORL J Otorhinolaryngol Relat Spec. 1982, 44:232-8. 10.1159\/000275597","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3937\/kampomed.74.342","article-title":"A case of atypical M\u00e9ni\u00e8re\u2019s disease with frequent urination successfully treated with Choreitogoshimotsuto","volume":"74","author":"Shirai A","year":"2023","unstructured":"Shirai A, Ogawa K. A case of atypical M\u00e9ni\u00e8re\u2019s disease with frequent urination successfully treated with Choreitogoshimotsuto. Kampo Med. 2023, 74:342-7. 10.3937\/kampomed.74.342","journal-title":"Kampo Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.5631\/jibirin.87.719","article-title":"Clinical experience with Sairei-to in the treatment of Meniere\u2019s disease","volume":"87","author":"Mizuta K","year":"1994","unstructured":"Mizuta K, Ito Y, Kondo Y, Miyata H. Clinical experience with Sairei-to in the treatment of Meniere\u2019s disease. Pract Otol. 1994, 87:719-26. 10.5631\/jibirin.87.719","journal-title":"Pract Otol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.5631\/jibirin.75.11special_2337","article-title":"Experience on treatment of M\u00e9ni\u00e8re\u2019s disease with herbal medicines","volume":"75","author":"Taguchi K","year":"1982","unstructured":"Taguchi K, Hirabayashi M, Ishiyama T. Experience on treatment of M\u00e9ni\u00e8re\u2019s disease with herbal medicines. Pract Otol. 1982, 75:2337-44. 10.5631\/jibirin.75.11special_2337","journal-title":"Pract Otol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2863","article-title":"Sodium and potassium changes during decongestion with acetazolamide - a pre-specified analysis from the ADVOR trial","volume":"25","author":"Dhont S","year":"2023","unstructured":"Dhont S, Martens P, Meekers E, et al.. Sodium and potassium changes during decongestion with acetazolamide - a pre-specified analysis from the ADVOR trial. Eur J Heart Fail. 2023, 25:1310-9. 10.1002\/ejhf.2863","journal-title":"Eur J Heart Fail"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb02655.x","article-title":"Influence of advanced age on the disposition of acetazolamide","volume":"19","author":"Chapron DJ","year":"1985","unstructured":"Chapron DJ, Sweeney KR, Feig PU, Kramer PA. Influence of advanced age on the disposition of acetazolamide. Br J Clin Pharmacol. 1985, 19:363-71. 10.1111\/j.1365-2125.1985.tb02655.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1989.tb03340.x","article-title":"Acetazolamide blood concentrations are excessive in the elderly: propensity for acidosis and relationship to renal function","volume":"29","author":"Chapron DJ","year":"1989","unstructured":"Chapron DJ, Gomolin IH, Sweeney KR. Acetazolamide blood concentrations are excessive in the elderly: propensity for acidosis and relationship to renal function. J Clin Pharmacol. 1989, 29:348-53. 10.1002\/j.1552-4604.1989.tb03340.x","journal-title":"J Clin Pharmacol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1967.00980030580003","article-title":"Potassium, acetazolamide, and intraocular pressure","volume":"78","author":"Spaeth GL","year":"1967","unstructured":"Spaeth GL. Potassium, acetazolamide, and intraocular pressure. Arch Ophthalmol. 1967, 78:578-82. 10.1001\/archopht.1967.00980030580003","journal-title":"Arch Ophthalmol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1001\/jama.205.7.492","article-title":"Licorice-induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity","volume":"205","author":"Conn JW","year":"1968","unstructured":"Conn JW, Rovner DR, Cohen EL. Licorice-induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity. JAMA. 1968, 205:492-6. 10.1001\/jama.205.7.492","journal-title":"JAMA"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(87)91014-2","article-title":"Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age","volume":"2","author":"Stewart PM","year":"1987","unstructured":"Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet. 1987, 2:821-4. 10.1016\/s0140-6736(87)91014-2","journal-title":"Lancet"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1161\/hy1101.096112","article-title":"In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice","volume":"38","author":"Ferrari P","year":"2001","unstructured":"Ferrari P, Sansonnens A, Dick B, Frey FJ. In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice. Hypertension. 2001, 38:1330-6. 10.1161\/hy1101.096112","journal-title":"Hypertension"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.719197","article-title":"Clinical risk factors of licorice-induced pseudoaldosteronism based on glycyrrhizin-metabolite concentrations: a narrative review","volume":"8","author":"Yoshino T","year":"2021","unstructured":"Yoshino T, Shimada S, Homma M, Makino T, Mimura M, Watanabe K. Clinical risk factors of licorice-induced pseudoaldosteronism based on glycyrrhizin-metabolite concentrations: a narrative review. Front Nutr. 2021, 8:719197. 10.3389\/fnut.2021.719197","journal-title":"Front Nutr"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3937\/kampomed.66.197","article-title":"Relationship between incidence of pseudoaldosteronism and daily dose of glycyrrhiza: review of the literature","volume":"66","author":"Mantani N","year":"2015","unstructured":"Mantani N, Oka H, Sahashi Y, et al.. Relationship between incidence of pseudoaldosteronism and daily dose of glycyrrhiza: review of the literature. Kampo Med. 2015, 66:197-202. 10.3937\/kampomed.66.197","journal-title":"Kampo Med"},{"key":"ref48","article-title":"Acetazolamide prophylaxis in hypokalaemic periodic paralysis","volume":"33","author":"Sinha SK","year":"1985","unstructured":"Sinha SK, Sharma SN, Prasad KC. Acetazolamide prophylaxis in hypokalaemic periodic paralysis. J Assoc Physicians India. 1985, 33:421-2.","journal-title":"J Assoc Physicians India"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31823a0cb6","article-title":"Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype","volume":"77","author":"Matthews E","year":"2011","unstructured":"Matthews E, Portaro S, Ke Q, et al.. Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype. Neurology. 2011, 77:1960-4. 10.1212\/WNL.0b013e31823a0cb6","journal-title":"Neurology"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.31.11.1423","article-title":"Hypokalemic periodic paralysis exacerbated by acetazolamide","volume":"31","author":"Torres CF","year":"1981","unstructured":"Torres CF, Griggs RC, Moxley RT, Bender AN. Hypokalemic periodic paralysis exacerbated by acetazolamide. Neurology. 1981, 31:1423-8. 10.1212\/wnl.31.11.1423","journal-title":"Neurology"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2008.01792.x","article-title":"Meniere's attacks occur in the inner ear with excessive vasopressin type-2 receptors","volume":"20","author":"Kitahara T","year":"2008","unstructured":"Kitahara T, Doi K, Maekawa C, Kizawa K, Horii A, Kubo T, Kiyama H. Meniere's attacks occur in the inner ear with excessive vasopressin type-2 receptors. J Neuroendocrinol. 2008, 20:1295-300. 10.1111\/j.1365-2826.2008.01792.x","journal-title":"J Neuroendocrinol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0b013e3181b11db5","article-title":"Plasma vasopressin and V2 receptor in the endolymphatic sac in patients with delayed endolymphatic hydrops","volume":"30","author":"Kitahara T","year":"2009","unstructured":"Kitahara T, Maekawa C, Kizawa K, Horii A, Doi K. Plasma vasopressin and V2 receptor in the endolymphatic sac in patients with delayed endolymphatic hydrops. Otol Neurotol. 2009, 30:812-9. 10.1097\/MAO.0b013e3181b11db5","journal-title":"Otol Neurotol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1177\/0194599818756829","article-title":"M\u00e9ni\u00e8re's disease pathophysiology: endolymphatic sac immunohistochemical study of aquaporin-2, V2R vasopressin receptor, NKCC2, and TRPV4","volume":"158","author":"Asmar MH","year":"2018","unstructured":"Asmar MH, Gaboury L, Saliba I. M\u00e9ni\u00e8re's disease pathophysiology: endolymphatic sac immunohistochemical study of aquaporin-2, V2R vasopressin receptor, NKCC2, and TRPV4. Otolaryngol Head Neck Surg. 2018, 158:721-8. 10.1177\/0194599818756829","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/ohn.386","article-title":"Immune-related disorders associated with M\u00e9ni\u00e8re's\u00a0disease: a systematic review and meta-analysis","volume":"169","author":"Lopez-Escamez JA","year":"2023","unstructured":"Lopez-Escamez JA, Vela J, Frejo L. Immune-related disorders associated with M\u00e9ni\u00e8re's\u00a0disease: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2023, 169:1122-31. 10.1002\/ohn.386","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref55","article-title":"Long-term effect of acetazolamide and chlorthalidone on the hearing loss of Meni\u00e8re's disease","volume":"10","author":"Corvera J","year":"1989","unstructured":"Corvera J, Corvera G. Long-term effect of acetazolamide and chlorthalidone on the hearing loss of Meni\u00e8re's disease. Am J Otol. 1989, 10:142-5.","journal-title":"Am J Otol"},{"key":"ref56","article-title":"[Treatment of vertigo cases with acetazolamide-diamox]","volume":"43","author":"Kirikae I","year":"1961","unstructured":"Kirikae I. [Treatment of vertigo cases with acetazolamide-diamox]. Therapy. 1961, 43:521-8.","journal-title":"Therapy"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-5998(95)70102-8","article-title":"Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meni\u00e8re's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc","volume":"113","year":"1995","unstructured":"Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meni\u00e8re's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg. 1995, 113.181-5. 10.1016\/S0194-5998(95)70102-8","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2273.2003.00687.x","article-title":"The AAO-HNS Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meni\u00e8re's disease: have they been applied in the published literature of the last decade?","volume":"28","author":"Thorp MA","year":"2003","unstructured":"Thorp MA, Shehab ZP, Bance ML, Rutka JA. The AAO-HNS Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meni\u00e8re's disease: have they been applied in the published literature of the last decade?. Clin Otolaryngol Allied Sci. 2003, 28:173-6. 10.1046\/j.1365-2273.2003.00687.x","journal-title":"Clin Otolaryngol Allied Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/294432-adverse-events-and-efficacy-of-acetazolamide-in-menieres-disease-in-a-vertigo-outpatient-clinic-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T01:20:04Z","timestamp":1726622404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/294432-adverse-events-and-efficacy-of-acetazolamide-in-menieres-disease-in-a-vertigo-outpatient-clinic-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":58,"URL":"https:\/\/doi.org\/10.7759\/cureus.69616","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,17]]}}}